Rocephin and Persantine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rocephin (ceftriaxone sodium) and Persantine (dipyridamole). Common drug interactions include gastroenteritis viral among females and upper respiratory tract infection among males.

The phase IV clinical study analyzes what interactions people have when they take Rocephin and Persantine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Rocephin?

Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.

What is Persantine?

Persantine has active ingredients of dipyridamole. eHealthMe is studying from 2,427 Persantine users. Check the latest studies of Persantine.



On Jul, 06, 2026

12 people who take Rocephin and Persantine together, and have interactions are studied.

Rocephin and Persantine drug interactions.

What are the common drug interactions of Rocephin and Persantine, by gender? *:

female:

  1. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  2. Loss of consciousness
  3. Activities of daily living impaired
  4. Adverse event
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Cardiac failure
  8. Emotional distress
  9. Pain
  10. Renal impairment (severely reduced kidney function)

male:

  1. Upper respiratory tract infection
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Lung neoplasm malignant (cancer tumour of lung)
  4. Cough
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Heart rate decreased
  7. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Rocephin and Persantine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain upper
  2. Asthenia (weakness)
  3. Atelectasis (partial or complete collapse of the lung)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Blood glucose increased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cardiac failure congestive
  8. Cardiomegaly (increased size of heart than normal)
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Chest discomfort

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  2. Loss of consciousness
  3. Pain
  4. Renal failure (kidney dysfunction)
  5. Renal impairment (severely reduced kidney function)
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Blood calcium increased
  8. Blood pressure increased
  9. Bradycardia (abnormally slow heart action)
  10. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 25.00%
  2. Urinary Tract Infection: 2 people, 16.67%
  3. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 16.67%
  4. Stable Angina (a constant chest pain): 1 person, 8.33%
  5. Peripartum Cardiomyopathy (deterioration in cardiac function presenting typically between the last month of pregnancy and up to five months postpartum): 1 person, 8.33%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
  7. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%
  8. High Blood Pressure: 1 person, 8.33%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
  10. Fever: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Rocephin and Persantine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rocephin and Persantine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rocephin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Persantine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rocephin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Persantine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium and dipyridamole (the active ingredients of Rocephin and Persantine, respectively), and Rocephin and Persantine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: